Venture Forum Highlights the 2008 M&A and IPO's in the Winner's Circle for Healthcare
22 Julho 2008 - 12:04PM
PR Newswire (US)
MASSAPEQUA, N.Y., July 22 /PRNewswire-FirstCall/ -- Conference
organizer International Business Forum will highlight this year's
MidAmerica Healthcare Winner's Circle on October 1st. Companies to
be awarded the M&A include Apptec, NimbleGen, and Renal
Solutions. Tomo Therapy is being awarded the IPO of the year. All
are in Recognition for Outstanding Deal Execution. Accepting the
award for Apptec is former CEO & Founder, Bonnie Baskin. Apptec
is a unique single source for the biopharmaceutical/biotechnology
and medical device/medical product industries -- offering testing,
contract research and development, and cGMP manufacturing services.
Apptec was acquired by WuXi PharmaTech (Cayman) Inc. in January of
2008 and is traded on NYSE as WX. The total value of the
transaction including payment of Apptec's debt was approximately
$151 million. Accepting the award for NimbleGen is Former Chairman,
Bob Palay. NimbleGen was acquired by Roche in June of 2007 and is
traded as ROG.VX. Under the terms of the agreement, Roche paid
NimbleGen's shareholders $272.5 million. NimbleGen is a leading
innovator, manufacturer and supplier of a proprietary suite of DNA
microarrays, consumables, instruments and services. Renal Solutions
Board Member, John McIlwraith Managing Director at Blue Chip
Venture Company will be accepting for the company. Renal Solutions
a wholly-owned subsidiary of Fresenius Medical Care, is leading the
advancement of sorbent therapy for improved renal replacement
therapy. Fresenius Medical Care acquired Renal Solutions back in
November 2007 for $200 million and is listed on the NYSE as FMS.
Board Member, John Neis Co-Founder & Managing Director of
Venture Investors, LLC will accept for Tomo Therapy. Tomo Therapy
is based in the U.S. with European offices in Belgium and
distribution throughout the world. The company owns multiple issued
U.S. patents and has a number of patent applications pending, both
in the U.S. and worldwide. The company also holds an exclusive
license on more than 100 issued patents and pending applications
globally. Tomo Therapy listed on NASDAQ May 2007 as TOMO. The
Winner's Circle is scheduled to take place 3:15 p.m. on Wednesday,
October 1st at The Westin Hotel in downtown Cincinnati. The session
will highlight what made these deals significant and how they came
together. This Venture Forum is the Midwest's largest annual event
showcasing biotech, pharma, medical devices, and industrial biotech
companies in the heartland of America. This event will unite the
venture capital community to drive innovation through investment
opportunities in the healthcare market. This forum is a must-attend
event for active investors in the Midwest. To learn more about the
event and to register, please visit
http://www.midamericahealthcareforum.com/. About IBF International
Business Forum presents financial and business conferences on
venture capital, corporate finance, mergers & acquisitions,
corporate strategic investing, defined contribution/401(k) plans,
risk management, funding technology innovation, and
commercialization of intellectual property. IBF conferences provide
attendees with leading-edge information and new business contacts
to achieve business objectives. Visit
http://www.ibfconferences.com/ for more details and complete
information on upcoming events. DATASOURCE: International Business
Forum CONTACT: Carissa Stavrakos, Executive Producer of
International Business Forum, Inc., +1-516-765-9005 x310, Web site:
http://www.ibfconferences.com/
http://www.midamericahealthcareforum.com/
Copyright